Fractures in chronic kidney disease: pursuing the best screening and management

Carregando...
Imagem de Miniatura
Citações na Scopus
26
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Citação
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, v.24, n.4, p.317-323, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Purpose of review Osteoporotic fractures are common and cause increased sickness and death. Men and women with chronic kidney disease (CKD) are at particularly high risk of osteoporotic fractures. Currently, however, there are no guidelines concerning noninvasive methods to assess fracture risk in CKD. Further, approved treatments to prevent fractures in otherwise healthy men and women are only recommended for use with caution in those with CKD. This review focuses on the recent data that support the use of noninvasive methods to assess fracture risk in CKD and highlights new therapies that could be used in fracture prevention in CKD. Recent findings Data from prospective studies demonstrate that low bone mineral density predicts fracture in CKD patients. Post-hoc analyses demonstrate that agents approved for the treatment of postmenopausal osteoporosis (bisphosphonates, denosumab and teriparatide) when given to those with CKD are well tolerated and potentially efficacious with respect to fracture risk reduction. Summary To date, patients, and nephrologists taking care of them, have largely ignored fracture risk assessment and treatment in CKD. This should change given recent data. Further studies are needed, specifically bone histomorphometric studies, which will increase our understanding of CKD-mineral bone disease (MBD) pathophysiology, and randomized clinical trials of therapy in patients with CKD.
Palavras-chave
bone disease, bone histomorphometry, CKD-MBD, fracture, osteoporosis, osteoporosis therapy
Referências
  1. Jamal SA, 2007, J BONE MINER RES, V22, P503, DOI 10.1359/JBMR.070112
  2. Bhagat YA, 2011, J MAGN RESON IMAGING, V33, P372, DOI 10.1002/jmri.22439
  3. de Oliveira RA, 2015, KIDNEY INT, V87, P1039, DOI 10.1038/ki.2014.372
  4. Cejka D, 2011, CLIN J AM SOC NEPHRO, V6, P2264, DOI 10.2215/CJN.09711010
  5. SABIN MA, 1995, CALCIFIED TISSUE INT, V56, P210, DOI 10.1007/BF00298612
  6. Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8
  7. Jamal SA, 2012, OSTEOPOROSIS INT, V23, P2805, DOI 10.1007/s00198-012-1908-y
  8. Akaberi S, 2008, AM J TRANSPLANT, V8, P2647, DOI 10.1111/j.1600-6143.2008.02423.x
  9. Ott SM, 2013, NAT REV NEPHROL, V9, P681, DOI 10.1038/nrneph.2013.182
  10. Miller PD, 2005, J BONE MINER RES, V20, P2105, DOI 10.1359/JBMR.050817
  11. Malluche HH, 2011, J BONE MINER RES, V26, P1368, DOI 10.1002/jbmr.309
  12. Kanis JA, 2009, BEST PRACT RES CL RH, V23, P711, DOI 10.1016/j.berh.2009.09.002
  13. de Oliveira RB, 2013, NEPHROL DIAL TRANSPL, V28, P2510, DOI 10.1093/ndt/gft234
  14. Pothuaud L, 2000, J BONE MINER RES, V15, P691, DOI 10.1359/jbmr.2000.15.4.691
  15. Naylor KL, 2015, CLIN J AM SOC NEPHRO, V10, P646, DOI 10.2215/CJN.06040614
  16. Block GA, 2012, J BONE MINER RES, V27, P1471, DOI 10.1002/jbmr.1613
  17. Yenchek RH, 2012, CLIN J AM SOC NEPHRO, V7, P1130, DOI 10.2215/CJN.12871211
  18. Ball AM, 2002, JAMA-J AM MED ASSOC, V288, P3014, DOI 10.1001/jama.288.23.3014
  19. Nair SS, 2013, CLIN J AM SOC NEPHRO, V8, P1336, DOI 10.2215/CJN.10901012
  20. Tentori F, 2014, KIDNEY INT, V85, P166, DOI 10.1038/ki.2013.279
  21. Nickolas TL, 2013, J BONE MINER RES, V28, P1811, DOI 10.1002/jbmr.1916
  22. Jamal SA, 2007, AM J KIDNEY DIS, V49, P674, DOI 10.1053/j.ajkd.2007.02.264
  23. [Anonymous], 2015, DRUG THER B, V53, P18
  24. Ishani A, 2008, J AM SOC NEPHROL, V19, P1430, DOI 10.1681/ASN.2007050555
  25. Parfitt AM, 1998, J BONE MINER RES, V13, P1213, DOI 10.1359/jbmr.1998.13.8.1213
  26. Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173
  27. Cejka D, 2010, KIDNEY BLOOD PRESS R, V33, P221, DOI 10.1159/000316708
  28. Wagner J, 2014, NEPHROL DIAL TRANSPL, V29, P146, DOI 10.1093/ndt/gft352
  29. Techawiboonwong A, 2008, RADIOLOGY, V248, P824, DOI 10.1148/radiol.2482071995
  30. Iimori S, 2012, NEPHROL DIAL TRANSPL, V27, P345, DOI 10.1093/ndt/gfr317
  31. McClung MR, 2014, NEW ENGL J MED, V370, P412, DOI 10.1056/NEJMoa1305224
  32. Nikkel LE, 2009, TRANSPLANTATION, V87, P1846, DOI 10.1097/TP.0b013e3181a6bbda
  33. Sabbagh Y, 2012, J BONE MINER RES, V27, P1757, DOI 10.1002/jbmr.1630
  34. West SL, 2015, J BONE MINER RES, V30, P913, DOI 10.1002/jbmr.2406
  35. Nickolas TL, 2010, J AM SOC NEPHROL, V21, P1371, DOI 10.1681/ASN.2009121208
  36. Trombetti A, 2013, OSTEOPOROSIS INT, V24, P1721, DOI 10.1007/s00198-012-2133-4
  37. Miller PD, 2007, OSTEOPOROSIS INT, V18, P59, DOI 10.1007/s00198-006-0189-8
  38. Jamal SA, 2011, J BONE MINER RES, V26, P1829, DOI 10.1002/jbmr.403
  39. Kaufman JM, 2013, BONE, V53, P134, DOI 10.1016/j.bone.2012.11.018
  40. Araujo MJCLN, 2014, KIDNEY WEEK PHILADEL, p246A
  41. Carvalho CG, 2015, PEDIATR NEPHROL, V30, P497, DOI 10.1007/s00467-014-2942-0
  42. Goncalves FLC, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-190
  43. Jorgetti V, 2009, NEPHROLOGY, V14, P404, DOI 10.1111/j.1440-1797.2009.01148.x
  44. Ketteler M, 2015, KIDNEY INT, V87, P502, DOI 10.1038/ki.2014.425
  45. Lim SY, 2015, CURR OPIN RHEUMATOL, V27, P216, DOI 10.1097/BOR.0000000000000169
  46. Miller Paul D, 2011, Ther Adv Musculoskelet Dis, V3, P271, DOI 10.1177/1759720X11424220
  47. Moe SM, 2009, KIDNEY INT S, V113, pS1